WARRICK 1621 (Griseofulvin (ultramicrocrystalline) 250 mg)
Pill imprint WARRICK 1621 has been identified as Griseofulvin (ultramicrocrystalline) 250 mg.
Griseofulvin is used in the treatment of tinea pedis; tinea barbae; tinea corporis; tinea capitis; onychomycosis, fingernail (and more), and belongs to the drug class miscellaneous antifungals. Risk cannot be ruled out during pregnancy. Griseofulvin 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WARRICK 1621 (Griseofulvin (ultramicrocrystalline) 250 mg)
Griseofulvin (ultramicrocrystalline)
- Imprint:
-
WARRICK
1621 - Strength:
- 250 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antifungals
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- ESI Lederle Generics
More resources
Griseofulvin (ultramicrocrystalline) is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
